. "3 GEIS at Naval Medical Research Unit 2, Indonesia." Perspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review. Washington, DC: The National Academies Press, 2001.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Perspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review
of Medicine for administrative support, including housing and force protection. In addition, NAMRU-2 receives funding from companies like Abbott Laboratories and SmithKline for support of collaborative projects. Fiscal year 2001 GEIS funding is expected to total $1,075,000 (GEIS, 2000c).
A subcommittee of the Institute of Medicine (IOM) Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System visited NAMRU-2 from October 2 to 5, 2000. The subcommittee also visited a newly developed extension facility in Phnom Penh, Cambodia, that NAMRU-2 operates jointly with the Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand, on October 6 and 7, 2000. The IOM subcommittee consisted of committee members Ruth Berkelman and Ronald St. John. A list of the people met and interviewed and the itinerary followed can be found at the end of this chapter.
NAMRU-2 houses an extensive laboratory facility within a 62,000square-foot laboratory, office, and storage space in Jakarta, Indonesia (GEIS, 2000e). The NAMRU-2 facility is collocated with the Directorate General of Communicable Disease Control and Environmental Health (a part of the MoH, hereafter referred to as “Indonesian CDC”) and the Litbangkes (Indonesian National Institute of Health Research and Development, part of the Indonesian Ministry of Health). Litbangkes allocates free space on the entire third floor of its building for NAMRU-2 laboratories. NAMRU-2 also occupies a large warehouse nearby that houses additional laboratories, materials and supplies, and administrative offices. The Association for the Assessment and Accreditation of Laboratory Animal Care-International accredits NAMRU-2 laboratory animal facilities (GEIS, 2000e).
NAMRU-2’s Jakarta laboratory is equipped to support medical research- and disease surveillance-related activities, activities that use approaches ranging from classical microbiology to modern molecular biology-based approaches. Within this facility, a conventional scientific organizational structure consisting of bacteriology, virology, parasitology, and entomology departments is maintained along with a recently added emerging infectious disease component. The NAMRU-2 laboratory facility in Jakarta possesses a biosafety level 2 (BSL-2) capacity and a nearly complete BSL-3 capacity. Specimens from fatal cases and pathogens with rapid incubation periods are sent to collaborators and supporting facilities that possess BSL-4 capabilities for analysis.
NAMRU-2 is establishing a subsidiary laboratory in Phnom Penh, Cambodia, to provide an operational base site to support disease surveillance and epidemiological activities. The Cambodian National Institute of